Archive \ Volume.12 2021 Issue 3

An Overview on Hypertension: Management Approach and Follow Up in Primary Health Care Center

Mohammed Mihmas B Alqahtani , Abdullah Faisal Islam , Ghadeer Abbas Katib , Lujain Faisal Islam , Abdullah Abdulmohsen Alhaddab , Hamad Yasser Alhassoun , Hawra Salman Alqattan , Anoud Abdulrahman Ahmad , Majed Muidh O Albogami , Sarah Alsalhi , Anwar Mohammed Al Hadhari , Abdullah Odhayb Alruwaili

Hypertension is one of the most common chronic diseases on earth. This condition works viciously on developing other lethal complications silently. The prevalence of hypertension among Saudi adults is close to 15%, hence it warrants a great deal of focus when it comes to early diagnosis and further management. We investigated the literature reviewing diagnosis of hypertension, risk factors, management, guidelines, and follow-up of this disease. PubMed database was used for the selection of articles, gathered papers had undergone a thorough review. Given a diagnosis of hypertension to a patient held more than what the eyes meet. This diagnosis gives a label to the patient who should carry it with them for the rest of their lives, thus it should be diagnosed carefully and accurately. This disease burden would be taken by the patient, their families, and the governmental bodies that provide health care. So strict measures should be taken in the diagnosis steps. Moreover, the family physician should be aware of the outline management of hypertension with the variability of different cases.

How to cite:
Alqahtani M M B, Islam A F, Katib G A, Islam L F, Alhaddab A A, Alhassoun H Y, et al. An Overview on Hypertension: Management Approach and Follow Up in Primary Health Care Center. Arch. Pharm. Pract. 2021;12(3):110-2.
Alqahtani, M. M. B., Islam, A. F., Katib, G. A., Islam, L. F., Alhaddab, A. A., Alhassoun, H. Y., & et al (2021). An Overview on Hypertension: Management Approach and Follow Up in Primary Health Care Center. Archives Of Pharmacy Practice, 12(3),110-112.

Download Citation

1.        Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724. doi:10.1016/S0140-6736(16)31679-8

2.        El Bcheraoui C, Memish ZA, Tuffaha M, Daoud F, Robinson M, Jaber S, et al. Hypertension and its associated risk factors in the kingdom of saudi arabia, 2013: a national survey. Int J Hypertens. 2014;2014:564679. doi:10.1155/2014/564679

3.        Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, et al. A New Algorithm for the Diagnosis of Hypertension in Canada. Can J Cardiol. 2015;31(5):620-30. doi:10.1016/j.cjca.2015.02.014

4.        Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, et al. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36(5):596-624. doi:10.1016/j.cjca.2020.02.086

5.        Veiga EV, Nogueira MS, Cárnio EC, Marques S, Lavrador MA, Moraes SA, et al. Assessment of the techniques of blood pressure measurement by health professionals. Arq Bras Cardiol. 2003;80(1):89-93. doi:10.1590/s0066-782x2003000100008

6.        Pescatello LS, MacDonald HV, Lamberti L, Johnson BT. Exercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging Research. Curr Hypertens Rep. 2015;17(11):87. doi:10.1007/s11906-015-0600-y

7.        Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3-10. doi:10.1056/NEJM200101043440101

8.        Cohen JB. Hypertension in Obesity and the Impact of Weight Loss. Curr Cardiol Rep. 2017;19(10):98. doi:10.1007/s11886-017-0912-4

9.        Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane database Syst Rev. 2018;4(4):CD001841. doi:10.1002/14651858.CD001841.pub3

10.      Aronow WS. Antihypertensive drug therapy. Ann Transl Med. 2018;6(7):123. doi:10.21037/atm.2018.01.26

11.      Park S. Ideal Target Blood Pressure in Hypertension. Korean Circ J. 2019;49(11):1002-9. doi:10.4070/kcj.2019.0261